Found 4 matching trials
A Study of SKLB1028 in Patients With Advanced Solid Tumor
PHASE1The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Location
Henan Cancer Hospital
A Dose Escalation and Food Effect Study of SKLB1028 in Healthy Subjects
PHASE1The purpose of this study was to explore the safety, tolerability and pharm...
Location
Beijing Friendship Hospital, Capital Medical University
A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
PHASE1Patients will receive oral SKLB1028 for 28 days to study the side effects, ...
Location
West China Hospital,Sichuan University
SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
PHASE1The purpose of this study is to describe the dose limiting toxicities (DLT)...
Location
West China Hospital of Sichuan University